Populations at highest risk for acquiring hepatitis B and C viral (HBV and HCV) infection, or developing serious complications from infection, also experience structural racism, stigma, and discrimination through disparities in healthcare access and other barriers that may lead to lower rates of screening and treatment and higher burden of disease in these underserved populations. Thus, HBV and HCV elimination efforts have provided inconsistent and inequitable outcomes, and health disparities for HBV and HCV persist. In this webinar, researchers working directly with racial and ethnic communities that experience disparate hepatitis outcomes will present models of care and interventions to address hepatitis health disparities. Appropriately tailored interventions that meet the context and culture of each community can ensure HBV and HCV elimination includes all populations in the United States.